Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Contributi Scientifici

No. 53 (2020)

Donne e tossicodipendenza. Quando la patologia è di altro genere…

DOI
https://doi.org/10.3280/mis53-2020oa9857
Submitted
maggio 21, 2020
Published
2020-05-21

Abstract

The European Drug Report 2017: Trends and Developments, published by the Libson based European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reports that only 20% of patients who undergo treatment for drug addiction are female (a male-female ratio of 4:1).
According to the EMCDDA, the reasons for this are varied and could include issues of access and appropriateness of service provision.
Using data from two trials conducted within the Department of Pathological Addictions of the Local Health Service of Taranto, this article’s intent is to highlight the necessity of specific focusing in terms of health, rehabilitation programmes, and access to services for women drug consumers and addicts.
Helping women addicts to become independent, making them aware of their own potential, offering them a real sense of self worth to value and defend, promoting the safeguarding of their own health; all these are essential elements of treatment and rehabilitation, for the prevention and limitation of any harm.

References

  1. (1) Healy B. (1991). The Yentl syndrome. N Engl J Med, 325: 274-6.
  2. (2) Clayton J.A., Collins F.S. (2014). Policy: NIH to balance sex in cell and animal studies. Nature, 509: 282-3.
  3. (3) Farkas R.H., Unger E.F., Temple R. (2013). Zolpidem and driving impairment-identifying persons at risk. N Engl J Med, 369: 689-91.
  4. (4) Franconi F., Brunelleschi S., Steardo L., Cuomo V. (2007). Gender differences in drug responses. Pharmacol Res, 55: 81-95.
  5. (5) Franconi F., Campesi I. (2014). Sex and gender influences on pharmacological response: an overview. Expert Rev Clin Pharmacol, 7: 469-85.
  6. (6) Franconi F., Campesi I. (2018). Farmacologia di genere. Milano: Il Pensiero Scientifico.
  7. (7) Graziani M., Nencini P., Nistico R. (2014). Genders and the concurrent use of cocaine and alcohol: Pharmacological aspects. Pharmacol Res, 87: 60-70.
  8. (8) Quaderni del Ministero della Salute, n. 26 aprile 2016 - Il genere come determinante di salute. Lo sviluppo della medicina di genere per garantire equità e appropriatezza della cura, p. 74.
  9. (9) Fischbach R.L., Herbert B. (1997). Domestic violence and mental health: correlates and conundrums within and across cultures. Social Sciences Medicine, 45(8): 1161-1176.
  10. (10) Stark E., Flitcraft A. (1991). Spouse abuse. In: Rosenberg M., Fenley M. (eds.), Violence in America: A Public Health Approach. New York: Oxford University Press.
  11. (11) Kilpatrick D.G., Saunders B., Veronen L.J., Best C.L., Von J. (1987). Criminal victimization: lifetime prevalence, reporting to police, and psychological impact. Crime and Delinquency, 33: 479-489.
  12. (12) Braitstein P., Li K., Tyndall M., Spittal P., O’Shaughnessy M.V., Schilder A., Clerici M. (1993),Tossicodipendenza e psicopatologia. Milano: FrancoAngeli.
  13. (13) Saraceno B. (2017). Navigare nei mari della salute mentale. In: Animazione sociale, fasc. 314, n. 9. Torino: Edizioni Gruppo Abele pp. 3-14.
  14. (14) Saraceno B., op. cit., p. 7.

Metrics

Metrics Loading ...